CHEMED CORP (CHE) Stock Fundamental Analysis

NYSE:CHE • US16359R1032

466.6 USD
-1.72 (-0.37%)
At close: Feb 25, 2026
466.6 USD
0 (0%)
After Hours: 2/25/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

CHE gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. CHE has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. CHE has a valuation in line with the averages, but on the other hand it scores bad on growth. CHE also has an excellent dividend rating. With these ratings, CHE could be worth investigating further for dividend investing!.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • CHE had positive earnings in the past year.
  • CHE had a positive operating cash flow in the past year.
  • CHE had positive earnings in 4 of the past 5 years.
  • Of the past 5 years CHE 4 years had a positive operating cash flow.
CHE Yearly Net Income VS EBIT VS OCF VS FCFCHE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

  • CHE has a better Return On Assets (17.17%) than 100.00% of its industry peers.
  • CHE has a Return On Equity of 25.89%. This is amongst the best in the industry. CHE outperforms 91.09% of its industry peers.
  • CHE's Return On Invested Capital of 21.27% is amongst the best of the industry. CHE outperforms 97.03% of its industry peers.
  • CHE had an Average Return On Invested Capital over the past 3 years of 21.96%. This is significantly above the industry average of 8.93%.
Industry RankSector Rank
ROA 17.17%
ROE 25.89%
ROIC 21.27%
ROA(3y)17.25%
ROA(5y)18.8%
ROE(3y)27.61%
ROE(5y)32.28%
ROIC(3y)21.96%
ROIC(5y)22.92%
CHE Yearly ROA, ROE, ROICCHE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

  • The Profit Margin of CHE (11.02%) is better than 96.04% of its industry peers.
  • In the last couple of years the Profit Margin of CHE has grown nicely.
  • CHE has a better Operating Margin (14.60%) than 87.13% of its industry peers.
  • CHE's Operating Margin has improved in the last couple of years.
  • CHE's Gross Margin of 32.88% is fine compared to the rest of the industry. CHE outperforms 63.37% of its industry peers.
  • In the last couple of years the Gross Margin of CHE has grown nicely.
Industry RankSector Rank
OM 14.6%
PM (TTM) 11.02%
GM 32.88%
OM growth 3Y-0.29%
OM growth 5Y3.39%
PM growth 3Y-0.36%
PM growth 5Y1.83%
GM growth 3Y-0.79%
GM growth 5Y1.99%
CHE Yearly Profit, Operating, Gross MarginsCHE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CHE is creating value.
  • There is no outstanding debt for CHE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CHE Yearly Shares OutstandingCHE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
CHE Yearly Total Debt VS Total AssetsCHE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • CHE has an Altman-Z score of 12.12. This indicates that CHE is financially healthy and has little risk of bankruptcy at the moment.
  • CHE has a Altman-Z score of 12.12. This is amongst the best in the industry. CHE outperforms 96.04% of its industry peers.
  • The Debt to FCF ratio of CHE is 0.00, which is an excellent value as it means it would take CHE, only 0.00 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.00, CHE belongs to the top of the industry, outperforming 93.07% of the companies in the same industry.
  • A Debt/Equity ratio of 0.00 indicates that CHE is not too dependend on debt financing.
  • CHE has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. CHE outperforms 86.14% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 12.12
ROIC/WACC2.45
WACC8.68%
CHE Yearly LT Debt VS Equity VS FCFCHE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 1.35 indicates that CHE should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.35, CHE perfoms like the industry average, outperforming 50.49% of the companies in the same industry.
  • A Quick Ratio of 1.33 indicates that CHE should not have too much problems paying its short term obligations.
  • The Quick ratio of CHE (1.33) is comparable to the rest of the industry.
  • The current and quick ratio evaluation for CHE is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 1.33
CHE Yearly Current Assets VS Current LiabilitesCHE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The earnings per share for CHE have decreased by -6.70% in the last year.
  • The Earnings Per Share has been growing slightly by 3.61% on average over the past years.
EPS 1Y (TTM)-6.7%
EPS 3Y3%
EPS 5Y3.61%
EPS Q2Q%-6%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-0.1%

3.2 Future

  • CHE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.66% yearly.
  • CHE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.00% yearly.
EPS Next Y18.87%
EPS Next 2Y13.19%
EPS Next 3Y11.66%
EPS Next 5YN/A
Revenue Next Year6.06%
Revenue Next 2Y5.13%
Revenue Next 3Y5%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
CHE Yearly Revenue VS EstimatesCHE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
CHE Yearly EPS VS EstimatesCHE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • CHE is valuated rather expensively with a Price/Earnings ratio of 21.61.
  • Compared to the rest of the industry, the Price/Earnings ratio of CHE indicates a somewhat cheap valuation: CHE is cheaper than 66.34% of the companies listed in the same industry.
  • CHE is valuated rather cheaply when we compare the Price/Earnings ratio to 27.05, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 18.18, the valuation of CHE can be described as rather expensive.
  • Based on the Price/Forward Earnings ratio, CHE is valued a bit cheaper than 67.33% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of CHE to the average of the S&P500 Index (28.03), we can say CHE is valued slightly cheaper.
Industry RankSector Rank
PE 21.61
Fwd PE 18.18
CHE Price Earnings VS Forward Price EarningsCHE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • CHE's Enterprise Value to EBITDA ratio is in line with the industry average.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CHE indicates a somewhat cheap valuation: CHE is cheaper than 68.32% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 18.33
EV/EBITDA 14.93
CHE Per share dataCHE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

  • CHE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The excellent profitability rating of CHE may justify a higher PE ratio.
PEG (NY)1.15
PEG (5Y)5.98
EPS Next 2Y13.19%
EPS Next 3Y11.66%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. Dividend

5.1 Amount

  • CHE has a yearly dividend return of 0.51%, which is pretty low.
  • Compared to an average industry Dividend Yield of 0.49, CHE pays a better dividend. On top of this CHE pays more dividend than 81.19% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.80, CHE's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.51%

5.2 History

  • On average, the dividend of CHE grows each year by 8.02%, which is quite nice.
  • CHE has paid a dividend for at least 10 years, which is a reliable track record.
  • CHE has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)8.02%
Div Incr Years16
Div Non Decr Years21
CHE Yearly Dividends per shareCHE Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • 11.01% of the earnings are spent on dividend by CHE. This is a low number and sustainable payout ratio.
  • The dividend of CHE is growing, but earnings are growing more, so the dividend growth is sustainable.
DP11.01%
EPS Next 2Y13.19%
EPS Next 3Y11.66%
CHE Yearly Income VS Free CF VS DividendCHE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
CHE Dividend Payout.CHE Dividend Payout, showing the Payout Ratio.CHE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CHEMED CORP

NYSE:CHE (2/25/2026, 8:04:00 PM)

After market: 466.6 0 (0%)

466.6

-1.72 (-0.37%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-25
Earnings (Next)04-21
Inst Owners101.64%
Inst Owner Change42.52%
Ins Owners1.52%
Ins Owner Change-1.18%
Market Cap6.61B
Revenue(TTM)N/A
Net Income(TTM)278.81M
Analysts82.5
Price Target566.61 (21.43%)
Short Float %4.66%
Short Ratio4.21
Dividend
Industry RankSector Rank
Dividend Yield 0.51%
Yearly Dividend1.83
Dividend Growth(5Y)8.02%
DP11.01%
Div Incr Years16
Div Non Decr Years21
Ex-Date02-23
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.99%
Min EPS beat(2)-15.11%
Max EPS beat(2)-2.88%
EPS beat(4)1
Avg EPS beat(4)-4.45%
Min EPS beat(4)-15.11%
Max EPS beat(4)0.5%
EPS beat(8)2
Avg EPS beat(8)-3.19%
EPS beat(12)4
Avg EPS beat(12)-2.23%
EPS beat(16)8
Avg EPS beat(16)-1.06%
Revenue beat(2)0
Avg Revenue beat(2)-1.85%
Min Revenue beat(2)-2.53%
Max Revenue beat(2)-1.17%
Revenue beat(4)0
Avg Revenue beat(4)-1.07%
Min Revenue beat(4)-2.53%
Max Revenue beat(4)-0.19%
Revenue beat(8)0
Avg Revenue beat(8)-1.28%
Revenue beat(12)2
Avg Revenue beat(12)-1.05%
Revenue beat(16)2
Avg Revenue beat(16)-1.24%
PT rev (1m)-3.27%
PT rev (3m)-3.27%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.01%
EPS NY rev (1m)-0.17%
EPS NY rev (3m)-0.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.04%
Valuation
Industry RankSector Rank
PE 21.61
Fwd PE 18.18
P/S 2.61
P/FCF 18.33
P/OCF 15.74
P/B 6.14
P/tB 20.34
EV/EBITDA 14.93
EPS(TTM)21.59
EY4.63%
EPS(NY)25.66
Fwd EY5.5%
FCF(TTM)25.46
FCFY5.46%
OCF(TTM)29.64
OCFY6.35%
SpS178.72
BVpS76.04
TBVpS22.94
PEG (NY)1.15
PEG (5Y)5.98
Graham Number192.19
Profitability
Industry RankSector Rank
ROA 17.17%
ROE 25.89%
ROCE 27.75%
ROIC 21.27%
ROICexc 23.56%
ROICexgc 62.89%
OM 14.6%
PM (TTM) 11.02%
GM 32.88%
FCFM 14.24%
ROA(3y)17.25%
ROA(5y)18.8%
ROE(3y)27.61%
ROE(5y)32.28%
ROIC(3y)21.96%
ROIC(5y)22.92%
ROICexc(3y)25.21%
ROICexc(5y)25.79%
ROICexgc(3y)67.33%
ROICexgc(5y)75.46%
ROCE(3y)28.73%
ROCE(5y)30.03%
ROICexgc growth 3Y-5.61%
ROICexgc growth 5Y0.34%
ROICexc growth 3Y-1.58%
ROICexc growth 5Y4.43%
OM growth 3Y-0.29%
OM growth 5Y3.39%
PM growth 3Y-0.36%
PM growth 5Y1.83%
GM growth 3Y-0.79%
GM growth 5Y1.99%
F-Score7
Asset Turnover1.56
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 92.02%
Cap/Sales 2.34%
Interest Coverage 250
Cash Conversion 96.74%
Profit Quality 129.28%
Current Ratio 1.35
Quick Ratio 1.33
Altman-Z 12.12
F-Score7
WACC8.68%
ROIC/WACC2.45
Cap/Depr(3y)89.59%
Cap/Depr(5y)94.39%
Cap/Sales(3y)2.41%
Cap/Sales(5y)2.56%
Profit Quality(3y)107.8%
Profit Quality(5y)110.23%
High Growth Momentum
Growth
EPS 1Y (TTM)-6.7%
EPS 3Y3%
EPS 5Y3.61%
EPS Q2Q%-6%
EPS Next Y18.87%
EPS Next 2Y13.19%
EPS Next 3Y11.66%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-0.1%
Revenue Next Year6.06%
Revenue Next 2Y5.13%
Revenue Next 3Y5%
Revenue Next 5YN/A
EBIT growth 1Y-7.92%
EBIT growth 3Y4.05%
EBIT growth 5Y8.18%
EBIT Next Year14.67%
EBIT Next 3Y10.29%
EBIT Next 5Y9.62%
FCF growth 1Y39.38%
FCF growth 3Y13.77%
FCF growth 5Y8.19%
OCF growth 1Y30.35%
OCF growth 3Y10.6%
OCF growth 5Y6.75%

CHEMED CORP / CHE FAQ

What is the fundamental rating for CHE stock?

ChartMill assigns a fundamental rating of 7 / 10 to CHE.


What is the valuation status of CHEMED CORP (CHE) stock?

ChartMill assigns a valuation rating of 4 / 10 to CHEMED CORP (CHE). This can be considered as Fairly Valued.


Can you provide the profitability details for CHEMED CORP?

CHEMED CORP (CHE) has a profitability rating of 9 / 10.


Can you provide the financial health for CHE stock?

The financial health rating of CHEMED CORP (CHE) is 9 / 10.


What is the earnings growth outlook for CHEMED CORP?

The Earnings per Share (EPS) of CHEMED CORP (CHE) is expected to grow by 18.87% in the next year.